Suchergebnisse - "Sökler, Martin"

PubPharm (40)

1

FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel - results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Lorenzen, S. | Thuss-Patience, P. | Pauligk, C. | +11

2

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma : follow-up analysis of a randomized phase II study from the German Hodgkin Study Group

enthalten in: Leukemia | 2022

von Damaschin, C. | Goergen, H. | Kreissl, S. | +13

3

Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy

enthalten in: Cancers | 2021

von Roerden, M. | Wirths, S. | Sökler, M. | +3

4

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Borchmann, P. | Plütschow, A. | Kobe, C. | +33

CommentIn: Lancet Oncol. 2021 Feb;22(2):161-162. - PMID 33539737

5

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The lancet / Oncology | 1 February 2021

von Borchmann, P. | Plütschow, A. | Kobe, C. | +33

6

Health-Related Quality of Life in Patients With Hodgkin Lymphoma : A Longitudinal Analysis of the German Hodgkin Study Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Kreissl, S. | Müller, H. | Goergen, H. | +15

CommentIn: J Clin Oncol. 2020 Sep 1;38(25):2821-2823. - PMID 32650684

7

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma : The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial

enthalten in: JAMA oncology | 2020

von Bröckelmann, P. | Goergen, H. | Keller, U. | +19

8

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma : benefit of obinutuzumab in reducing the rate of early progression

enthalten in: Haematologica | 2020

von Seymour, J. | Marcus, R. | Davies, A. | +11

ErratumFor: Haematologica. 2019 Jun;104(6):1202-1208. - PMID 30573503

9

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experience

enthalten in: Annals of hematology | 2020

von Roerden, M. | Sökler, M. | Kanz, L. | +3

10

Computed tomography texture analysis for assessment of chemotherapy response of Hodgkin lymphoma

enthalten in: Medicine | 2020

von Reinert, C. | Wanek, L. | Bösmüller, H. | +4